Rivia
Zurich, Switzerland · $15.0M raised
- Total Funding
- $15.0M
- Last Round
- $15.0M Series AMar 2026
- Rounds
- 1
About
AI-powered data analytics platform unifying clinical trial data for biopharma companies.
Summary
Rivia is a Biotech company based in Zurich, Switzerland. It has raised $15.0M in total across 1 round, most recently a $15.0M Series A round in Mar 2026. Investors include Earlybird Venture Capital, Defiant and Speedinvest.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2026
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company